AngioLab (XKRX:251280) Short-Term Capital Lease Obligation : ₩60.8 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Short-Term Capital Lease Obligation?

AngioLab's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩60.8 Mil.

AngioLab's quarterly Short-Term Capital Lease Obligation increased from Dec. 2021 (₩49.6 Mil) to Dec. 2022 (₩58.7 Mil) and increased from Dec. 2022 (₩58.7 Mil) to Dec. 2023 (₩60.8 Mil).

AngioLab's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩49.6 Mil) to Dec. 2022 (₩58.7 Mil) and increased from Dec. 2022 (₩58.7 Mil) to Dec. 2023 (₩60.8 Mil).

AngioLab Short-Term Capital Lease Obligation Historical Data

The historical data trend for AngioLab's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Short-Term Capital Lease Obligation Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

49.41

49.62

58.68

60.81

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			49.41	49.62	49.62	58.68	60.81

AngioLab Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

AngioLab Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of AngioLab's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines